Related Experiment Video
Updated: Jun 7, 2025
An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
Published on: March 18, 2015
Various crystalline forms of realgar exhibit differentiated anti-abscess and anticancer effects based on a PXRD
Taotao Wang1, Xinyue Zhang1, Kunmei Shan1
1Development and Utilization Key Laboratory of Northeast Plant Materials, Key Laboratory of Northeast Authentic Materials Research and Development in Liaoning Province, School of Traditional Chinese Meteria Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Ethnopharmacological Relevance:
Realgar is a mineral medicine with a long history that can be used externally or internally. It is often used to treat skin diseases and leukemia in clinical practice. Realgar exhibits a polycrystalline phenomenon, and it remains unknown whether there is a difference in the efficacies of the different realgar crystalline forms.
Purpose:
The aim of this study is to investigate the pharmacodynamic differences of the different realgar crystalline forms (α-As4S4 and β-As4S4) using in vivo and in vitro experiments.
Material And Methods:
The in realgar crystalline patterns were initially identified using a powder x-ray diffractometer (PXRD). The antimicrobial activities of α-As4S4 and β-As4S4 were then assessed in vitro to elucidate their effectiveness against bacteria. Transdermal absorption and pharmacokinetic experiments were used to investigate the variances in the bioavailabilities between the in vitro and in vivo conditions. The effects of α-As4S4 and β-As4S4 for skin abscess healing were studied in mice using a subcutaneous injection of Staphylococcus aureus (S. aureus). HL-60 cells were exposed to a serum that contained different crystalline forms of realgar to evaluate the potential differences in the therapeutic effects of α-As4S4 and β-As4S4 on leukemia.
Results:
Realgar is composed of α-As4S4 and β-As4S4 crystalline forms. The soluble arsenic content in α-As4S4 generally exceeded that of β-As4S4, and the antimicrobial activity showed a positive correlation with the soluble arsenic content. α-As4S4 demonstrated a higher in vivo and in vitro bioavailability and a faster elimination rate in vivo compared to β-As4S4. The pharmacodynamic experimental investigations showed that α-As4S4 exhibited a superior healing effect on subcutaneous abscesses. Furthermore, serum pharmacology experiments revealed that α-As4S4 induced significantly higher membrane damage and apoptosis in HL-60 cells compared to β-As4S4.
Conclusion:
The different realgar crystalline forms had distinct pharmacodynamics. α-As4S4 demonstrated higher bioavailability in vitro and in vivo and superior effects on skin abscess healing compared to β-As4S4. It also possessed anti-leukemia properties. It is the first time to report the differences in the efficacy between two crystalline forms of realgar, which is helpful to improve the knowledge of the real chemical substances for realgar.
